Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioLine RX Ltd (NASDAQ:BLRX)

1.09
Delayed Data
As of Sep 20
 +0.01 / +0.93%
Today’s Change
0.80
Today|||52-Week Range
1.42
+18.48%
Year-to-Date
No recent news for BioLine RX Ltd.

Today’s Trading

Previous close1.08
Today’s open1.07
Day’s range1.06 - 1.09
Volume147,540
Average volume (3 months)479,519
Market cap$112.4M
Dividend yield--
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)-0.36%
Earnings growth (this year)--
Earnings growth (next 5 years)-25.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
CPIXCumberland Pharmaceu...-0.03-0.42%
--EcoGreen Internation...+0.02+13.29%
ORMPOramed Pharmaceutica...-0.09-0.94%
AGRXAgile Therapeutics I...+0.10+2.75%
Data as of 09/20/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$15.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Head-Investor Relations
Philip Adam Serlin
Chief Financial Officer
Mali Zeevi
Corporate headquarters
Modi'in, Tel Aviv

Forecasts